You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic granulocytic leukemia (CGL)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Treatment Pathway in Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
    • Argentina, Argentina
    • +17 more
    Aug 9, 2022

    Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 12, 2023

    Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    • Tucson, Arizona
    • +40 more
    Dec 20, 2022

    CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

    Recruiting
    • CLL
    • +9 more
    • TG-1801
    • Ublituximab
    • Fayetteville, Arkansas
    • +4 more
    Jan 20, 2023

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Hyperbaric oxygen
    • Rochester, New York
      Wilmot Cancer Institute, University of Rochester
    May 16, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 12, 2023

    Chronic Myeloid Leukemia Trial in France (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Amiens, France
    • +14 more
    Mar 3, 2023

    Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

    Withdrawn
    • Drug/Agent Toxicity by Tissue/Organ
    • +3 more
    • amifostine trihydrate
    • +2 more
    • Chicago, Illinois
    • +3 more
    Jan 31, 2023

    Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Condition Vasoregulation Function Endothelium in CML Getting TKI

    Recruiting
    • Chronic Myeloid Leukaemia
    • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
    • Moscow, Russian Federation
    • +1 more
    Jan 11, 2023

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

    Recruiting
    • Myelofibrosis
    • +2 more
    • Charlottesville, Virginia
      Danyelle Coley
    Jan 18, 2023

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Untreated Chronic Lymphocytic Leukemia Trial in Topeka, Omaha

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Cholecalciferol
    • Laboratory Biomarker Analysis
    • Topeka, Kansas
    • +1 more
    Aug 4, 2022

    CLL, SLL, HCL Trial in Dresden

    Recruiting
    • CLL
    • +7 more
      • Dresden, Sachsen, Germany
        BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
      Apr 29, 2022

      Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

      Recruiting
      • Relapsed or Refractory CD19+ B-cell Lymphoma
      • +2 more
      • TBI-2001
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jul 26, 2023

      Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

      Recruiting
      • Non Hodgkin Lymphoma
      • +2 more
      • Fully human anti CD19 CAR-T Cell Dose
      • +2 more
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Oct 4, 2022

      Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

      Recruiting
      • Acute Lymphoblastic Leukemia, Adult B-Cell
      • +3 more
      • clonoSEQ Assay
      • Stanford, California
      • +15 more
      Jan 30, 2023

      Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Chronic Myelomonocytic Leukemia
      • Baltimore, Maryland
      • +3 more
      Aug 8, 2022

      Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

      Active, not recruiting
      • Chronic Myelomonocytic Leukemia
      • Leukemia
      • Tampa, Florida
      • +4 more
      Nov 11, 2022

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

      Active, not recruiting
      • Recurrent Chronic Lymphoid Leukemia
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 19, 2022